MedTrace Logo

Streamlining the Efficiency of PrEP Implementation

NCT04424524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 746

Last updated 2024-08-13

No results posted yet for this study

Summary

This is a pilot facility-based direct-to-pharmacy PrEP refill delivery to streamline care pathway in Kenyan public health HIV facilities implementing PrEP. Data on up to 500 PrEP users will be evaluated to understand delivery efficiency and in-depth interview with users and delivery key informants will be conducted to identify barriers and facilitators of implementation.

Conditions

  • HIV Prevention
  • HIV Preexposure Prophylaxis
  • Implementation

Interventions

OTHER

Direct-to-pharmacy oral PrEP refill visits

Programmatic direct-to-pharmacy oral PrEP refill visits supported with client HIV self-testing

Sponsors & Collaborators

Principal Investigators

  • Kenneth Mugwanya, MBChB, PhD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2023-06-30
Completion
2024-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04424524 on ClinicalTrials.gov